Pedia-Lax Enema Interactions
There are 407 drugs known to interact with Pedia-Lax Enema (sodium biphosphate / sodium phosphate), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 109 are major, 297 are moderate, and 1 is minor.
- View all 407 medications that may interact with Pedia-Lax Enema
- View Pedia-Lax Enema alcohol/food interactions (1)
- View Pedia-Lax Enema disease interactions (6)
Most frequently checked interactions
View interaction reports for Pedia-Lax Enema (sodium biphosphate / sodium phosphate) and the medicines listed below.
- acetaminophen
- albuterol
- albuterol / ipratropium
- amantadine
- Animal Shape Vitamins (multivitamin)
- Artane (trihexyphenidyl)
- atropine ophthalmic
- Atrovent HFA (ipratropium)
- azithromycin
- bacitracin / diperodon / neomycin / polymyxin b topical
- baclofen
- cholecalciferol
- diazepam
- ferrous sulfate
- gabapentin
- glycopyrrolate
- ibuprofen
- ipratropium
- Keppra (levetiracetam)
- midazolam
- MiraLAX (polyethylene glycol 3350)
- mupirocin topical
- nystatin topical
- omeprazole
- oxygen
- polyethylene glycol 3350
- senna
- sodium chloride
- Tylenol (acetaminophen)
- zinc oxide topical
Pedia-Lax Enema alcohol/food interactions
There is 1 alcohol/food interaction with Pedia-Lax Enema (sodium biphosphate / sodium phosphate).
Pedia-Lax Enema disease interactions
There are 6 disease interactions with Pedia-Lax Enema (sodium biphosphate / sodium phosphate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
Report options
More about Pedia-Lax Enema (sodium biphosphate / sodium phosphate)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.